Clinical Trials Logo

Filter by:
NCT ID: NCT06337734 Completed - Hypertension Clinical Trials

An Artificial Intelligence-Assisted Digital Health Lifestyle Intervention for Adults With Hypertension

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

This study evaluates the impact of a fully digital, autonomous, and artificial intelligence (AI)-driven lifestyle coaching program on managing blood pressure (BP) among adults diagnosed with hypertension. Participants received a BP monitor and a wearable activity tracker to facilitate data collection. This data, along with responses from a questionnaire mobile app, were analyzed by an automated analytics engine employing statistical and machine learning techniques. The program delivered tailored lifestyle coaching directly to participants through a mobile app, aiming for precise and effective BP management.

NCT ID: NCT06337721 Not yet recruiting - Clinical trials for Alcohol Use Disorder

Preventing Alcohol Use Disorders and Alcohol-Related Harms in Pacific Islander Young Adults

Start date: September 2024
Phase: N/A
Study type: Interventional

This study will: (1) refine and finalize the SPEAR intervention manual for preventing alcohol use disorders (AUD) and associated harms for Pacific Islander young adults; and (2) test SPEAR for efficacy by conducting a pretest-posttest randomized controlled trial (RCT).

NCT ID: NCT06337708 Recruiting - Diabetes Mellitus Clinical Trials

Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for African American Women

Start date: January 19, 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test a culturally tailored, smartphone-delivered intervention designed to increase physical activity and reduce risk for heart disease and type 2 diabetes among African American women.

NCT ID: NCT06337643 Active, not recruiting - Clinical trials for Pneumococcal Vaccine

A Study to Evaluate Tolerability, Safety and Immunogenicity of MVX01 Pneumococcal Vaccine

Start date: March 7, 2023
Phase: Phase 1
Study type: Interventional

The objectives of this first-in-human study is to evaluate the tolerability, safety, and immunogenicity of MVX01, a pneumococcal vaccine candidate, at four dose levels.

NCT ID: NCT06337552 Recruiting - Rectal Cancer Clinical Trials

High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)

Start date: February 19, 2024
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the feasibility and acceptability of a dietary intervention (FEED-FF) that includes fermented foods (FF), among locally advanced rectal cancer patients, and to explore whether this diet can improve outcomes in rectal cancer patients receiving chemoradiotherapy (CRT).

NCT ID: NCT06337526 Not yet recruiting - Clinical trials for Complex Regional Pain Syndromes

Predicting Pain Exacerbations in Children With Complex Regional Pain Syndrome (CRPS)

Start date: July 2024
Phase:
Study type: Observational

objectives: identify physiologic, dietary, and environment triggers of severe pain exacerbations in children with CRPS.

NCT ID: NCT06337331 Withdrawn - Clinical trials for Acute Myeloid Leukemia

Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant

Start date: August 31, 2024
Phase: Phase 2
Study type: Interventional

Patients eligible for a mismatch allogeneic stem cell transplant will receive Venetoclax daily for 7 days prior to transplant in addition to the following chemotherapy regimen: Decitabine daily for 5 days, Fludarabine daily for 5 days, and Busulfan daily for 2 days followed by 1 day of total body irradiation. Stem cell transplant will occur thereafter.

NCT ID: NCT06337305 Completed - Bladder Cancer Clinical Trials

Resiliency in Patients Undergoing Radical Cystectomy for Bladder Cancer

Start date: August 19, 2020
Phase:
Study type: Observational

This is a prospective cross-sectional survey-based study composed of both a retrospective chart review and 3-series patient survey. This study will help elicit potential areas throughout the perioperative course of radical cystectomy to improve patient resilience and quality of life, providing opportunity for future interventional studies.

NCT ID: NCT06337162 Not yet recruiting - Clinical trials for Hepatocellular Carcinoma

Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC)

HCC
Start date: May 1, 2024
Phase: Phase 1
Study type: Interventional

This is a pilot safety study of the oral PD-L1 inhibitor INCB099280 in patients with HCC awaiting liver transplant.

NCT ID: NCT06337097 Recruiting - Clinical trials for Immune Checkpoint Therapy

STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy

Start date: February 2, 2024
Phase: Phase 3
Study type: Interventional

To learn if monitoring blood levels of heart injury (troponin levels) in cancer participants treated with immune checkpoint inhibitors will lead to decreased heart-related side effects.